Publications
-
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
Molecular Genetics and Metabolism; 2013 Jan;108(1):56-64, ISSN 1096-7192, DOI 10.1016/j.ymgme.2012.11.010.
Yap TL ,Velayati A, Sidransky E, Lee JC (2012) -
Lack of exon 10 in the murine tau gene results in mild sensorimotor defects with aging
BMC Neuroscience; doi:10.1186/1471-2202-14-148.
Gumucio, Lannfelt, Nilsson (2012) -
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease.
PLoS One; DOI: 10.1371/journal.pone.0076523.
Meredith Jr., Sankaranarayanan, Guss et al (2012) -
Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein
International immunopharmacology vol. 16,4 (2013): 424-8. doi:10.1016/j.intimp.2013.04.034
Smith, Lynnae M et al (2012) -
Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells.
The Journal of Biological Chemistry; doi: 10.1074/jbc.M113.490102.
Jean-Marie Sontag, Viyada Nunbhakdi-Craig, and Estelle Sontag (2012) -
The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Ab Oligomers through Tau Phosphorylation
Neuron, 2013 doi: 10.1016/j.neuron.2013.02.003.
Mairet-Coello, Georges et al (2012) -
Molecular Mechanism of Tau Aggregation Induced by Anionic and Cationic Dyes
IOS Press; DOI: 10.3233/JAD-121765
Lira-De León, García-Gutiérrez, Serratos et al (2012) -
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Neurobiology of Aging; doi:10.1016/j.neurobiolaging.2012.05.010.
Acker C M, Forest S K, Zinkowski R, et al (2012) -
Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity
Int Immunopharmacol; 2012 Sep 28. doi: 10.1016/j.intimp.2012.09.007..
Smith LM, Klaver AC, Coffey MP et al (2011) -
Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening
J Biol Chem.; DOI: 10.1074/jbc.M112.379792
Bidinosti M, Shimshek DR, Mollenhauer B, et al (2011) -
Lowered Serum Amyloid-β1-42 Autoantibodies in Individuals with Lifetime Depression
Journal of Alzheimer’s Disease; 2012 Jul 5. DOI: 10.3233/JAD-2012-120625
Maetzler W, Langkamp M, Lerche S et al (2011) -
Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis
FEBS Letters (2012), doi:10.1016/j.febslet.2012.06.040
Tavassoly, O., Lee, J.S. (2011) -
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo.
Neurotherapeutics; Volume 9, Number 2, 464-476, DOI: 10.1007/s13311-012-0105-1.
Prabhudesai, S., Sinha, S., Attar, A., et al (2011) -
New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders
J Pharm Bioallied Sci.; 2012 Apr-Jun; 4(2): 112–117. doi: 10.4103/0975-7406.9481; PMCID: PMC3341714
Vasudevaraju, P., Guerrero, E., Hegde, ML, et al (2011) -
An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology
Acta Neuropathologica; 2012, DOI: 10.1007/s00401-012-0964-x.
Kovacs, GG, Wagner, U., Dumont, B. et al (2011) -
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Journal of Neurochemistry; 120: 440–452. 2012 Feb; doi: 10.1111/j.1471-4159.2011.07576.x.
Martin, Z. S., Neugebauer, V., Dineley, K. T., et al (2011) -
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells
Neuroscience Letters; Volume 507, Issue 2, 24 January 2012, Pages 133–136 DOI:10.1016/j.neulet.2011.12.001.
Tousi, A.S., Buck, D.J., Curtis, T., et al (2011) -
A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of A 38, A 40, and A 42 in Cerebrospinal Fluid of Alzheimer’s Disease Patients and Healthy Controls
Journal of Alzheimer’s Disease; DOI: 10.3233/JAD-2012-121471.
Pannee J, Portelius E, Oppermann M et al (2011) -
Methods for Measuring Tau Pathology in Transgenic Mouse Models
Journal of Alzheimer’s Disease; DOI 10.3233/JAD-2012-121354
Forest SK, Acker CM, d'Abramo C, Davies P. (2011) -
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Journal of Neurochemistry; https://doi.org/10.1111/j.1471-4159.2012.07911.x.
Luk C, Compta Y, Magdalinou N, et al (2011)